Target intelligence / Profile preview

Large ribosomal subunit protein uL23 (uL23)

Target
uL23
Molecular classification
Ribosomal protein, Structural protein, Other
01

Overview

Large ribosomal subunit protein uL23 (commonly called L23 in bacteria) is an essential and highly conserved structural protein component of the bacterial 50S ribosomal subunit[5][8]. It participates early in ribosome assembly, binding 23S rRNA, and is crucial for bacterial cell growth[8]. L23 forms part of the polypeptide exit tunnel, where newly synthesized proteins exit the ribosome, and serves as an interaction platform for protein biogenesis factors, such as the chaperone trigger factor and the signal recognition particle[1][2][8]. It is a critical structural and functional element of the translation machinery, making it a target for some antibiotics that bind near or at the tunnel exit to inhibit protein synthesis[1][2]. The protein's functional equivalents in other organisms include L25 in yeast and L23a in eukaryotes[1][5].

Other names
Ribosomal protein L2350S ribosomal protein L23rplW (gene)ribosomal protein L25 in yeastribosomal protein L23a in some eukaryotes
02

Mechanism of action

Inhibition of protein synthesis by binding near the ribosomal exit tunnel, preventing elongation or proper folding of nascent polypeptides

03

Biological functions

Ribosome assemblyProtein synthesis (translation)rRNA bindingNascent polypeptide exit tunnel formationInteraction with protein folding and targeting machinery such as the chaperone trigger factor
04

Disease associations

Infection (as an antibiotic target in bacteria)Other
05

Safety considerations

Potential toxicity to mitochondrial or eukaryotic ribosomes if drugs are not highly selective for bacterial L23Development of antibiotic resistance
06

Interacting drugs

Some ribosome-targeting antibiotics such as macrolides, although direct binding to L23 varies between drugs; L23 is located near or part of the polypeptide exit tunnel, a common antibiotic binding site in the bacterial ribosome
07

Biomarkers

null (L23 itself is not used as a clinical biomarker)

Beyond the preview

Go deeper on Large ribosomal subunit protein uL23 (uL23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large ribosomal subunit protein uL23 (uL23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call